This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Elastrin Therapeutics Limited

Profile

Elastrin Therapeutics has developed a nanotechnology capable of reversing chronic cardiovascular and lung diseases by regenerating damaged elastin. Our lead compound will be in clinical trials next year in an orphan indication, and we have just received Rare Pediatric Disease Designation by the FDA. Our latest innovation is a therapeutic mRNA and has just started preclinical development.